Bloomberg
Feburary 14, 2012
Today, GlaxoSmithKline Plc settled nearly 25,000 cases about its Avandia diabetes drug in mediation as the multi-district litigation was winding down. US District Cynthia gave the parties 75 days back in November 2011 to resolve 85% of the casesand it seems likely that with todays “major success” the parties have met that threshold.
ADR Times is an online dispute resolution community and trusted news source exploring mediation, arbitration, negotiation, diplomacy, and peace. ADR Times publishes articles, news and debates, and provides an industry directory, event calendar, job board, and community space for public and professionals to connect and share insights. We welcome you to join our growing community!
-SUBSCRIBE-
Subscribe to the coveted ADR Times mailing list to receive occasional updates, our Weekly Wrap, quarterly Perspectives on Dispute Resolution publication, and much more. We won’t spam you and value our relationship quite dearly!
Heck, you even get a chance to win a new iPad!
Reader Comments